Take the next step to see if you qualify for this Atopic Dermatitis (AD) study.
But don’t delay — space is limited!
Take the next step to see if you qualify for this Atopic Dermatitis (AD) study.
But don’t delay — space is limited!
Investigational Treatment Study for
Moderate-to-Severe Atopic Dermatitis (AD)
Investigational Treatment Study for
Moderate-to-Severe Atopic Dermatitis (AD)
A research study is enrolling today!
Those who qualify may receive:
- Study-related medical evaluations.
- Study treatment.*
- Compensation up to $2,660 for time and travel upon completion of the study.
During the 1st part of the study, some individuals will be assigned to a group treated with placebo, an inactive substance that has no medical effect. During the 2nd part of the study, all eligible participants will receive the active investigational treatment.
If you’re 18 years old or older, take the next step to see if you qualify for a local research study for people with moderate-to-severe atopic dermatitis, also called eczema.
But don’t delay — space is limited!
A research study is enrolling today!
Those who qualify may receive:
- Study-related medical evaluations.
- Study treatment.*
- Compensation up to $2,660 for time and travel upon completion of the study.
During the 1st part of the study, some individuals will be assigned to a group treated with placebo, an inactive substance that has no medical effect. During the 2nd part of the study, all eligible participants will receive the active investigational treatment.
If you’re 18 years old or older, take the next step to see if you qualify for a local research study for people with moderate-to-severe atopic dermatitis, also called eczema.
But don’t delay — space is limited!
Intense Itch. Redness. Sleep Loss.
Moderate-to-Severe Eczema Affects Every Part of Life
Moderate-to-severe eczema symptoms can feel unbearable. This is especially true of intensely itchy skin—but inflammation, broken skin, swelling, dry/scaly patches, and pain also interfere with everyday life. If you suffer from frequent flares and find that ointments and creams don’t help enough, it’s because the problem isn’t only skin deep.
In individuals with eczema, bacteria, viruses, and substances such as irritants and allergens easily enter the bloodstream through cracks in the outermost layer of skin (the skin barrier). Once in the bloodstream, the immune system—which normally functions to protect us from harmful agents in the environment—overreacts, leading to eczema symptoms. Scratching provides momentarily relief, but it also contributes to the itch-scratch-itch cycle.
Right now, we are seeking volunteers with moderate-to-severe eczema to join a study evaluating the effectiveness and safety of an investigational treatment being developed to inhibit (restrain) the overactive immune response in people with eczema. It may protect against or clear the symptoms caused by the disease.
Your participation could help expand treatment options for others who also suffer from eczema. See if you qualify today.
How does the online screener work?
Answer some questions about your health
Tell us a little bit about yourself
Connect to a study site in your area
Just takes a few minutes
AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.
Terms of Use/Privacy Policy
©2023 Acurian, Inc. All rights reserved.
*In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study.
